Who Owns Zai Lab Stock?
NASDAQ: ZLABHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 38.46%
- Held by insiders
- 2.12%
- Institutional holders
- 127
- Institutions 38.5%
- Insiders 2.1%
- Public and other 59.4%
Who owns Zai Lab stock?
Institutional investors own about 38.5% of Zai Lab's shares, spread across 127 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 2.12% of ZLAB.
The largest institutional holders are RTW Investments LP (5.78%), TCG Crossover Management, LLC (5.39%) and RA Capital Management, L.P. (5.05%). Together, the top 10 institutions control 29.9% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their ZLAB positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ZLAB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| RTW Investments LP | 6.57M | 5.78% | 0.0% |
| TCG Crossover Management, LLC | 6.14M | 5.39% | +100.0% |
| RA Capital Management, L.P. | 5.74M | 5.05% | +0.6% |
| Adar1 Capital Management, LLC | 3.37M | 2.96% | +136.4% |
| FMR, LLC | 2.82M | 2.47% | +123.0% |
| Goldman Sachs Group Inc | 2.32M | 2.03% | +1993.8% |
| Woodline Partners LP | 2.21M | 1.94% | +100.0% |
| Frazier Life Sciences Management, L.P. | 1.90M | 1.67% | 0.0% |
| BAMCO Inc. | 1.62M | 1.43% | -2.1% |
| Two Sigma Investments, LP | 1.30M | 1.14% | +319.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ZLAB
| Fund | Shares | % Held |
|---|---|---|
| BARON SELECT FUNDS-Baron Emerging Markets Fund | 1.37M | 1.20% |
| iShares Trust-iShares Biotechnology ETF | 670.07K | 0.59% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 331.78K | 0.29% |
| abrdn World Healthcare Fund | 311.29K | 0.27% |
| Tema ETF Trust-Tema Oncology ETF | 196.97K | 0.17% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company K6 Fund | 132.34K | 0.12% |
| ALPS ETF TRUST-ALPS Medical Breakthroughs ETF | 115.03K | 0.10% |
| BARON SELECT FUNDS-Baron International Growth Fund | 81.82K | 0.07% |
| ETFis Series Trust I-Virtus Biotech ETF | 79.50K | 0.07% |
| Brinker Capital Destinations TRT-Destinations Intl Eqy. Fd. | 75.57K | 0.07% |
Frequently asked questions
Who is the largest shareholder of Zai Lab?
RTW Investments LP is the largest institutional shareholder of ZLAB, owning 5.78% of shares outstanding (6.57M shares) as of its latest 13F filing.
What percentage of Zai Lab is owned by institutions?
Institutions own about 38.5% of ZLAB shares and 39.3% of the public float.
How much of Zai Lab do insiders own?
Insiders, such as officers and directors, own about 2.12% of ZLAB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.